跳至主要内容
临床试验/NCT06539663
NCT06539663已完成2 期

The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients

Farwaniya Hospital2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2022年4月10日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
5
试验地点
2
主要终点
Size of corneal perforation

研究概览

简要总结

Case series of 5 ICU patients in Farwaniya Hospital who developed exposure keratitis and a subsequent small corneal perforation between April 2022 and April 2024.

The investigators highlight the non-surgical role of OmniLenz® in the treatment of small corneal perforations secondary to exposure keratitis. The inclusion criteria were corneal perforation less than 1mm in size, positive culture & sensitivity results and showing initial improvement on topical antibiotic eye drops.

详细描述

The primary outcome measures were healing of the corneal perforation, a negative Seidel test and reformation of the anterior chamber.

Secondary outcome measures were improvement of all three of ciliary injection, state of epithelial defect, and corneal infiltration.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Patients with small corneal perforations measuring < 1 mm in diameter. Those with larger perforations (>1mm) were excluded.
  • Patients with conclusive results of keratitis (confirmed via culture and sensitivity scraping) AND showing improved keratitis following antibiotic treatment. Those with no confirmed keratitis through C&S or with inconclusive scraping results were excluded.
  • No age or gender restrictions were applied.

结局指标

主要结局

Size of corneal perforation

时间窗: one week

Size of corneal perforation will be measured in mm using slit lamp examination

次要结局

  • size of epithelial defect(one week)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Nancy Lotfy, MD

Associate Professor of Ophthalmology

Cairo University

研究点 (2)

Loading locations...

相似试验